Tapewire

NYSE · USD

ABT

ABBOTT LABORATORIES

Export transactions ↓
Tapewire entity
2314
SEC CIK
0000001800
Parsed reports
2,562

Last 12 months

Inside the activity.

6 purchase rows · 11 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202610
Feb 202620
Mar 202606
Apr 202620
May 202610
Jun 202600
Jul 202600
Aug 202603
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 19, 2006 Filed Jul 21, 2006 21:15 UTC Exercise / conversionCommon shares without par value 1,870 $23.23 $43,443.65
Disclosure

SEC source: 0001104659-06-048259 · a4.xml · nonDerivative · entry 1

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,872

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 01, 2006 Filed Jul 5, 2006 22:31 UTC
Tyree James LSenior Vice President
Tax withholdingCommon shares without par value 2,806 $43.18 $121,163.08
Disclosure

SEC source: 0001104659-06-045423 · a4.xml · nonDerivative · entry 1

Tyree James L · CIK 0001324991 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,726

Read SEC document
June 30, 2006 Filed Jul 5, 2006 21:50 UTC GrantStock equivalent units · Derivative 458 $43.61 Strike: $0.00 $19,973.38
Disclosure

SEC source: 0001104659-06-045402 · a4.xml · derivative · entry 1

DALEY WILLIAM M · CIK 0001183865 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,086

Underlying: common shares · 458 shares

Expires not disclosed

F1 · derivative.exercise_price: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
June 30, 2006 Filed Jul 5, 2006 21:49 UTC
Fussell Stephen RSenior Vice President
Exercise / conversionOption (right to buy) · Derivative 480 $0.00 Strike: $42.42 $0.00
Disclosure

SEC source: 0001104659-06-045401 · a4.xml · derivative · entry 7

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common shares · 480 shares

Expires 2006-12-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
June 30, 2006 Filed Jul 5, 2006 21:49 UTC
Fussell Stephen RSenior Vice President
Exercise / conversionOption (right to buy) · Derivative 3,800 $0.00 Strike: $41.01 $0.00
Disclosure

SEC source: 0001104659-06-045401 · a4.xml · derivative · entry 6

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common shares · 3,800 shares

Expires 2006-12-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
June 30, 2006 Filed Jul 5, 2006 21:49 UTC
Fussell Stephen RSenior Vice President
SaleCommon shares without par value 480 $43.43 $20,846.40
Disclosure

SEC source: 0001104659-06-045401 · a4.xml · nonDerivative · entry 4

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,161

Read SEC document
June 30, 2006 Filed Jul 5, 2006 21:49 UTC
Fussell Stephen RSenior Vice President
Exercise / conversionCommon shares without par value 480 $42.42 $20,362.85
Disclosure

SEC source: 0001104659-06-045401 · a4.xml · nonDerivative · entry 3

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,641

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 30, 2006 Filed Jul 5, 2006 21:49 UTC
Fussell Stephen RSenior Vice President
SaleCommon shares without par value 3,800 $43.00 $163,400.00
Disclosure

SEC source: 0001104659-06-045401 · a4.xml · nonDerivative · entry 2

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,161

Read SEC document
June 30, 2006 Filed Jul 5, 2006 21:49 UTC
Fussell Stephen RSenior Vice President
Exercise / conversionCommon shares without par value 3,800 $41.01 $155,838.00
Disclosure

SEC source: 0001104659-06-045401 · a4.xml · nonDerivative · entry 1

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,961

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 30, 2006 Filed Jul 5, 2006 22:30 UTC GrantStock equivalent units · Derivative 286 $43.61 Strike: $0.00 $12,472.46
Disclosure

SEC source: 0001104659-06-045421 · a4.xml · derivative · entry 1

POWELL BOONE JR · CIK 0001232973 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,371

Underlying: common shares · 286 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
June 30, 2006 Filed Jul 5, 2006 22:31 UTC GrantStock equivalent units · Derivative 550 $43.61 Strike: $0.00 $23,985.50
Disclosure

SEC source: 0001104659-06-045422 · a4.xml · derivative · entry 1

SMITHBURG WILLIAM D · CIK 0001190304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,956

Underlying: common shares · 550 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
June 30, 2006 Filed Jul 5, 2006 22:35 UTC
LIEPMANN HOLGER AExecutive Vice President
GrantOption (right to buy) · Derivative 2,362 $0.00 Strike: $42.90 $0.00
Disclosure

SEC source: 0001104659-06-045425 · a4.xml · derivative · entry 9

LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,362

Underlying: Common shares · 2,362 shares

Expires 2013-02-13

F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
June 30, 2006 Filed Jul 5, 2006 22:35 UTC
LIEPMANN HOLGER AExecutive Vice President
Exercise / conversionOption (right to buy) · Derivative 3,050 $0.00 Strike: $33.23 $0.00
Disclosure

SEC source: 0001104659-06-045425 · a4.xml · derivative · entry 8

LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common shares · 3,050 shares

Expires 2013-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
June 30, 2006 Filed Jul 5, 2006 22:35 UTC
LIEPMANN HOLGER AExecutive Vice President
GrantOption (right to buy) · Derivative 15,033 $0.00 Strike: $42.90 $0.00
Disclosure

SEC source: 0001104659-06-045425 · a4.xml · derivative · entry 7

LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,033

Underlying: Common shares · 15,033 shares

Expires 2013-02-13

F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
June 30, 2006 Filed Jul 5, 2006 22:35 UTC
LIEPMANN HOLGER AExecutive Vice President
Exercise / conversionOption (right to buy) · Derivative 17,409 $0.00 Strike: $33.23 $0.00
Disclosure

SEC source: 0001104659-06-045425 · a4.xml · derivative · entry 6

LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 822

Underlying: Common shares · 17,409 shares

Expires 2013-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
June 30, 2006 Filed Jul 5, 2006 22:35 UTC
LIEPMANN HOLGER AExecutive Vice President
Tax withholdingCommon shares without par value 17,395 $42.90 $746,245.50
Disclosure

SEC source: 0001104659-06-045425 · a4.xml · nonDerivative · entry 2

LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,142

Read SEC document
June 30, 2006 Filed Jul 5, 2006 22:35 UTC
LIEPMANN HOLGER AExecutive Vice President
Exercise / conversionCommon shares without par value 20,459 $33.23 $679,881.21
Disclosure

SEC source: 0001104659-06-045425 · a4.xml · nonDerivative · entry 1

LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,537

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 29, 2006 Filed Jun 30, 2006 19:00 UTC
Fussell Stephen RSenior Vice President
Exercise / conversionOption (right to buy) · Derivative 163 $0.00 Strike: $41.92 $0.00
Disclosure

SEC source: 0001104659-06-044878 · a4.xml · derivative · entry 4

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common shares · 163 shares

Expires 2006-12-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
June 29, 2006 Filed Jun 30, 2006 19:00 UTC
Fussell Stephen RSenior Vice President
SaleCommon shares without par value 163 $42.92 $6,995.96
Disclosure

SEC source: 0001104659-06-044878 · a4.xml · nonDerivative · entry 2

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,161

Read SEC document
June 29, 2006 Filed Jun 30, 2006 19:00 UTC
Fussell Stephen RSenior Vice President
Exercise / conversionCommon shares without par value 163 $41.92 $6,832.16
Disclosure

SEC source: 0001104659-06-044878 · a4.xml · nonDerivative · entry 1

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,324

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 26, 2006 Filed Jun 28, 2006 21:08 UTC
Fussell Stephen RSenior Vice President
SaleCommon shares without par value 2,500 $42.01 $105,025.00
Disclosure

SEC source: 0001104659-06-044171 · a4.xml · nonDerivative · entry 1

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,161

Read SEC document
June 13, 2006 Filed Jun 15, 2006 19:46 UTC GrantOption (right to buy) · Derivative 1,017 $0.00 Strike: $42.72 $0.00
Disclosure

SEC source: 0001104659-06-041947 · a4.xml · derivative · entry 7

SMITHBURG WILLIAM D · CIK 0001190304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,017

Underlying: Common Shares · 1,017 shares

Expires 2006-12-30

F2 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program. It includes a replacement option feature.

Read SEC document
June 13, 2006 Filed Jun 15, 2006 19:46 UTC Exercise / conversionOption (right to buy) · Derivative 1,796 $0.00 Strike: $24.20 $0.00
Disclosure

SEC source: 0001104659-06-041947 · a4.xml · derivative · entry 6

SMITHBURG WILLIAM D · CIK 0001190304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common shares · 1,796 shares

Expires 2006-12-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program. It includes a replacement option feature.

Read SEC document
June 13, 2006 Filed Jun 15, 2006 19:46 UTC Exercise / conversionOption (right to buy) · Derivative 1,870 $0.00 Strike: $23.23 $0.00
Disclosure

SEC source: 0001104659-06-041947 · a4.xml · derivative · entry 5

SMITHBURG WILLIAM D · CIK 0001190304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common shares · 1,870 shares

Expires 2006-09-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program. It includes a replacement option feature.

Read SEC document
June 13, 2006 Filed Jun 15, 2006 19:46 UTC Tax withholdingCommon shares without par value 2,033 $42.72 $86,849.76
Disclosure

SEC source: 0001104659-06-041947 · a4.xml · nonDerivative · entry 3

SMITHBURG WILLIAM D · CIK 0001190304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,656

Read SEC document
June 13, 2006 Filed Jun 15, 2006 19:46 UTC Exercise / conversionCommon shares without par value 1,796 $24.20 $43,463.02
Disclosure

SEC source: 0001104659-06-041947 · a4.xml · nonDerivative · entry 2

SMITHBURG WILLIAM D · CIK 0001190304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,689

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 13, 2006 Filed Jun 15, 2006 19:46 UTC Exercise / conversionCommon shares without par value 1,870 $23.23 $43,443.65
Disclosure

SEC source: 0001104659-06-041947 · a4.xml · nonDerivative · entry 1

SMITHBURG WILLIAM D · CIK 0001190304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,893

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 05, 2006 Filed Jun 7, 2006 21:01 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 7,666 $42.68 $327,184.88
Disclosure

SEC source: 0001104659-06-040304 · a4.xml · nonDerivative · entry 5

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Indirect · By wife

Disclosed balance after: 7,600

F1 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife.

Read SEC document
June 05, 2006 Filed Jun 7, 2006 21:01 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 25,000 $42.93 $1,073,125.00
Disclosure

SEC source: 0001104659-06-040304 · a4.xml · nonDerivative · entry 4

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 373,572

Read SEC document
June 05, 2006 Filed Jun 7, 2006 21:01 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 25,000 $42.79 $1,069,625.00
Disclosure

SEC source: 0001104659-06-040304 · a4.xml · nonDerivative · entry 3

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 398,572

Read SEC document
June 05, 2006 Filed Jun 7, 2006 21:01 UTC
GONZALEZ RICHARD ADirector · President and COO
SaleCommon shares without par value 734 $42.72 $31,356.48
Disclosure

SEC source: 0001104659-06-040304 · a4.xml · nonDerivative · entry 2

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 423,572

Read SEC document
June 02, 2006 Filed Jun 5, 2006 19:31 UTC
Fussell Stephen RSenior Vice President
SaleCommon shares without par value 174 $43.16 $7,509.84
Disclosure

SEC source: 0001104659-06-039716 · a4.xml · nonDerivative · entry 2

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,661

Read SEC document
June 01, 2006 Filed Jun 5, 2006 19:31 UTC
Fussell Stephen RSenior Vice President
Tax withholdingCommon shares without par value 511 $42.95 $21,947.45
Disclosure

SEC source: 0001104659-06-039716 · a4.xml · nonDerivative · entry 1

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,835

Read SEC document
May 09, 2006 Filed May 11, 2006 20:46 UTC Exercise / conversionOption (right to buy) · Derivative 1,549 $0.00 Strike: $24.20 $0.00
Disclosure

SEC source: 0001104659-06-033857 · a4.xml · derivative · entry 5

FULLER H LAURANCE · CIK 0001187553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: common shares · 1,549 shares

Expires 2006-12-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program. It contains a replacement option feature.

Read SEC document
May 09, 2006 Filed May 11, 2006 20:46 UTC Exercise / conversionOption (right to buy) · Derivative 1,613 $0.00 Strike: $23.23 $0.00
Disclosure

SEC source: 0001104659-06-033857 · a4.xml · derivative · entry 4

FULLER H LAURANCE · CIK 0001187553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: common shares · 1,613 shares

Expires 2006-09-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program. It contains a replacement option feature.

Read SEC document
May 09, 2006 Filed May 11, 2006 20:46 UTC SaleCommon shares without par value 3,162 $42.30 $133,752.60
Disclosure

SEC source: 0001104659-06-033857 · a4.xml · nonDerivative · entry 3

FULLER H LAURANCE · CIK 0001187553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,650

Read SEC document
May 09, 2006 Filed May 11, 2006 20:46 UTC Exercise / conversionCommon shares without par value 1,549 $24.20 $37,485.65
Disclosure

SEC source: 0001104659-06-033857 · a4.xml · nonDerivative · entry 2

FULLER H LAURANCE · CIK 0001187553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,812

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 09, 2006 Filed May 11, 2006 20:46 UTC Exercise / conversionCommon shares without par value 1,613 $23.23 $37,473.05
Disclosure

SEC source: 0001104659-06-033857 · a4.xml · nonDerivative · entry 1

FULLER H LAURANCE · CIK 0001187553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,263

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 09, 2006 Filed Jun 7, 2006 21:01 UTC
GONZALEZ RICHARD ADirector · President and COO
GiftCommon shares without par value 1,569 $0.00 $0.00
Disclosure

SEC source: 0001104659-06-040304 · a4.xml · nonDerivative · entry 1

GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 424,306

Read SEC document
May 08, 2006 Filed May 10, 2006 19:32 UTC Salecommon shares without par value 1,798 $42.37 $76,181.26
Disclosure

SEC source: 0001104659-06-033230 · a4.xml · nonDerivative · entry 3

POWELL BOONE JR · CIK 0001232973 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,045

Read SEC document
May 08, 2006 Filed May 10, 2006 19:32 UTC Salecommon shares without par value 3,100 $42.36 $131,316.00
Disclosure

SEC source: 0001104659-06-033230 · a4.xml · nonDerivative · entry 2

POWELL BOONE JR · CIK 0001232973 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,843

Read SEC document
May 08, 2006 Filed May 10, 2006 19:32 UTC Salecommon shares without par value 1,100 $42.35 $46,585.00
Disclosure

SEC source: 0001104659-06-033230 · a4.xml · nonDerivative · entry 1

POWELL BOONE JR · CIK 0001232973 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,943

Read SEC document
May 01, 2006 Filed May 2, 2006 21:39 UTC
Tyree James LSenior Vice President
SaleCommon shares without par value 137 $43.01 $5,892.37
Disclosure

SEC source: 0001104659-06-030331 · a4.xml · nonDerivative · entry 2

Tyree James L · CIK 0001324991 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,532

Read SEC document
May 01, 2006 Filed May 2, 2006 21:39 UTC
Tyree James LSenior Vice President
Tax withholdingCommon shares without par value 403 $42.60 $17,165.79
Disclosure

SEC source: 0001104659-06-030331 · a4.xml · nonDerivative · entry 1

Tyree James L · CIK 0001324991 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,669

Read SEC document
April 28, 2006 Filed May 2, 2006 21:33 UTC GrantCommon shares without par value 2,127 $0.00 $0.00
Disclosure

SEC source: 0001104659-06-030319 · a4.xml · nonDerivative · entry 1

SMITHBURG WILLIAM D · CIK 0001190304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,023

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or a change in control (as defined in the Program).

Read SEC document
April 28, 2006 Filed May 2, 2006 21:33 UTC GrantCommon shares without par value 2,127 $0.00 $0.00
Disclosure

SEC source: 0001104659-06-030321 · a4.xml · nonDerivative · entry 1

AUSTIN ROXANNE S · CIK 0001061632 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,860

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

Read SEC document
April 28, 2006 Filed May 2, 2006 21:33 UTC GrantCommon shares without par value 2,127 $0.00 $0.00
Disclosure

SEC source: 0001104659-06-030320 · a4.xml · nonDerivative · entry 1

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,002

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

Read SEC document
April 28, 2006 Filed May 2, 2006 21:35 UTC GrantCommon shares without par value 2,127 $0.00 $0.00
Disclosure

SEC source: 0001104659-06-030323 · a4.xml · nonDerivative · entry 1

FARRELL W JAMES · CIK 0001021872 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,127

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

Read SEC document
April 28, 2006 Filed May 2, 2006 21:35 UTC GrantCommon shares without par value 2,127 $0.00 $0.00
Disclosure

SEC source: 0001104659-06-030324 · a4.xml · nonDerivative · entry 1

WALTER JOHN R · CIK 0001046302 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,602

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

Read SEC document
April 28, 2006 Filed May 2, 2006 21:34 UTC GrantCommon shares without par value 2,127 $0.00 $0.00
Disclosure

SEC source: 0001104659-06-030322 · a4.xml · nonDerivative · entry 1

DALEY WILLIAM M · CIK 0001183865 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,516

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.